As of January 22, 2025, Aura Biosciences (AURA) has a market cap of $0.40 billion USD. According to our data, Aura Biosciences is ranked No.6402 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.40 B |
-3.53%
|
Dec 31, 2024 | $0.41 B |
-7.22%
|
Dec 29, 2023 | $0.44 B |
-15.62%
|
Dec 30, 2022 | $0.52 B |
-38.16%
|
Dec 31, 2021 | $0.85 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Immunocore
IMCR
|
$1.55 B |
0.000 M
|
UK
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Market Cap | = | AURA Stock Price | * | AURA Shares Outstanding |
= | $7.93 | * | 49.95 M | |
= | $0.40 B |